Skip to main content

Achieve Life Sciences (ACHV) Receives a Buy from JonesTrading

Tipranks - Tipranks - Tue Sep 23, 2025

In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Achieve Life Sciences, with a price target of $20.00. The company’s shares opened today at $2.85.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Walsh is a 3-star analyst with an average return of 2.1% and a 33.96% success rate. Walsh covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Achieve Life Sciences, and Y-Mabs Therapeutics.

Currently, the analyst consensus on Achieve Life Sciences is a Strong Buy with an average price target of $14.60, which is a 412.28% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $12.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $5.31 and a one-year low of $1.84. Currently, Achieve Life Sciences has an average volume of 1.39M.

Read More on ACHV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).